UBS Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Buy |
|
|||||
|
2025
Q1 | $160K | Sell |
|
|||||
|
2024
Q4 | $681K | Buy |
|
|||||
|
2024
Q3 | $53.2K | Buy |
|
|||||
|
2024
Q2 | $93.2K | Sell |
|
|||||
|
2024
Q1 | $324K | Sell |
|
|||||
|
2023
Q4 | $461K | Buy |
|
|||||
|
2023
Q3 | $53.7K | Sell |
|
|||||
|
2023
Q2 | $92.8K | Buy |
|
|||||
|
2023
Q1 | $45.4K | Buy |
|
|||||
|
2022
Q4 | $81.6K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.46M | Sell |
|
|||||
|
2021
Q4 | $2.02M | Buy |
|
|||||
|
2021
Q3 | $537K | Buy |
|
|||||
|
2021
Q2 | $259K | Sell |
|
|||||
|
2021
Q1 | $1.4M | Buy |
|
|||||
|
2020
Q4 | $4K | Buy |
|